Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PHILADELPHIA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- CS Disco Inc. (NYSE: LAW) – Securities Fraud Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Baxter International Inc. (NYSE: BAX): Grabar Law Office is investigating claims on behalf of shareholders of Baxter International Inc. (NYSE:...
-
PHILADELPHIA, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ: ALT): Grabar Law Office is investigating claims on behalf of shareholders of Altimmune, Inc. (NASDAQ: ALT). The...
-
PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA , Oct. 13, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX): Grabar Law Office is investigating claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc....